{"schema_version":"1","generated_at":"2026-10-30T11:03:52.012Z","data_as_of":null,"url":"https://www.findmykol.com/kol/evan-osmundson","json_url":"https://www.findmykol.com/kol/evan-osmundson/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"evan-osmundson","name":"Evan Osmundson","credential":"MD, PhD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Vanderbilt University","institution_url":"https://www.findmykol.com/institution/vanderbilt-university-medical-center","city":"Nashville","state":"TN","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1225347636","openalex":"A5052168030"},"summary":"Evan Osmundson is an Oncology physician affiliated with Vanderbilt University. OpenAlex indexes 88 publications with 1,969 citations (h-index 16); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":88,"cited_by_count":1969,"h_index":16,"latest_activity_year":2026,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06110572","title":"Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation","phase":"PHASE1/PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Vanderbilt-Ingram Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT06110572","trial_url":"https://www.findmykol.com/trial/NCT06110572"},{"nct":"NCT05996432","title":"Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy","phase":"EARLY_PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Vanderbilt-Ingram Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT05996432","trial_url":"https://www.findmykol.com/trial/NCT05996432"},{"nct":"NCT05501665","title":"Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer","phase":"PHASE1/PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Vanderbilt-Ingram Cancer Center","source_url":"https://clinicaltrials.gov/study/NCT05501665","trial_url":"https://www.findmykol.com/trial/NCT05501665"}],"source":"trials"},"payments":{"company_count":3,"program_years":{"first":2021,"last":null},"rows_total":4,"shown":3,"withheld":1,"rows":[{"payer":"Siemens Medical Solutions USA, Inc.","program_year":2025,"amount_usd":2699.36,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225347636"},{"payer":"Celgene Corporation","program_year":2025,"amount_usd":170.25,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225347636"},{"payer":"Siemens Medical Solutions USA, Inc.","program_year":2024,"amount_usd":2172.5,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1225347636"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1225347636","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Nervous system","share_pct":100,"classes_total":1,"classes":[{"class":"Gabapentinoids","setting":"prescribed","share_pct":100,"drugs":[{"name":"Gabapentin","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":6.7,"facility_pct":93.3},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2022,"last":2023},"rows_total":2,"shown":2,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R21CA274426","title":"Non-invasive, image-based, in-vivo assessment of tumor hypoxia to guide hypoxia-driven adaptive radiation therapy","fiscal_year":2023,"amount_usd":"158251","organization":"VANDERBILT UNIVERSITY MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R21CA274426"},{"project":"R21CA274426","title":"Non-invasive, image-based, in-vivo assessment of tumor hypoxia to guide hypoxia-driven adaptive radiation therapy","fiscal_year":2022,"amount_usd":"231643","organization":"VANDERBILT UNIVERSITY MEDICAL CENTER","source_url":"https://reporter.nih.gov/quickSearch/R21CA274426"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026","year":2026,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2026.0002","status":"verified"},{"title":"Magnetic resonance imaging to detect tumor hypoxia in brain malignant disease: A systematic review of validation studies","year":2025,"journal":"Clinical and Translational Radiation Oncology","source_url":"https://doi.org/10.1016/j.ctro.2025.100940","status":"verified"},{"title":"Assessing the Accuracy and Reliability of AI-Generated Medical Responses: An Evaluation of the Chat-GPT Model","year":2023,"journal":"Research Square","source_url":"https://doi.org/10.21203/rs.3.rs-2566942/v1","status":"verified"},{"title":"Accuracy and Reliability of Chatbot Responses to Physician Questions","year":2023,"journal":"JAMA Network Open","source_url":"https://doi.org/10.1001/jamanetworkopen.2023.36483","status":"verified"},{"title":"Chemoimmunotherapy for Untreated Lung Cancer Brain Metastases: Systemic Before Local Therapy?","year":2023,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.23.02151","status":"verified"}],"source":"works"},"contact":{"address_1":"3601 THE VANDERBILT CLINIC","city":"Nashville","state":"TN","zip":"372320021","phone":"615-936-2000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1225347636","source":"identity"},"similar":[{"name":"William Schaffner","slug":"william-schaffner","institution":"Vanderbilt University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/william-schaffner","json_url":"https://www.findmykol.com/kol/william-schaffner/profile.json"},{"name":"Keith Obstein","slug":"keith-obstein","institution":"Vanderbilt University","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/keith-obstein","json_url":"https://www.findmykol.com/kol/keith-obstein/profile.json"},{"name":"Devika Nair","slug":"devika-nair","institution":"Vanderbilt University","specialty":"Nephrology","url":"https://www.findmykol.com/kol/devika-nair","json_url":"https://www.findmykol.com/kol/devika-nair/profile.json"},{"name":"Andrew Jallouk","slug":"andrew-jallouk","institution":"Vanderbilt University","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/andrew-jallouk","json_url":"https://www.findmykol.com/kol/andrew-jallouk/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":1,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-03-29","provider_certified":"2022-03-29","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}